Zaninello, Marta
Palikaras, Konstantinos http://orcid.org/0000-0001-6992-5560
Naon, Deborah http://orcid.org/0000-0002-9726-4664
Iwata, Keiko
Herkenne, Stephanie
Quintana-Cabrera, Ruben http://orcid.org/0000-0002-0601-349X
Semenzato, Martina
Grespi, Francesca
Ross-Cisneros, Fred N.
Carelli, Valerio
Sadun, Alfredo A.
Tavernarakis, Nektarios http://orcid.org/0000-0002-5253-1466
Scorrano, Luca http://orcid.org/0000-0002-8515-8928
Article History
Received: 5 February 2020
Accepted: 21 July 2020
First Online: 12 August 2020
Competing interests
: V.C. and A.A.S. are investigators in clinical trials with Leber’s hereditary optic neuropathy (LHON) sponsored by Edison Pharmaceuticals, GenSight Pharmaceuticals, and Stealth BioTherapeutics; V.C. is an investigator in a clinical trial with LHON sponsored by Santhera Pharmaceuticals, and both V.C. and A.A.S. have been consultants for Santhera; A.A.S. is consultant for Stealth BioTherapeutics. The remaining authors declare no competing interests.